From October 1, 2023 to December 31, 2023, the company has repurchased 220,300 shares, representing 0.02% for CNY 4.25 million. With this, the company has completed the repurchase of 220,300 shares, representing 0.02% for CNY 4.25 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
34.01 CNY | -0.76% | +1.13% | +11.45% |
Apr. 22 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 19 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+11.45% | 6.65B | |
+16.16% | 8.15B | |
+3.59% | 7.52B | |
-7.15% | 3.73B | |
-6.11% | 3.72B | |
+1.10% | 1.31B | |
+15.20% | 972M | |
-36.30% | 958M | |
-16.77% | 876M | |
-18.44% | 783M |
- Stock Market
- Equities
- 300765 Stock
- News CSPC Innovation Pharmaceutical Co., Ltd.
- Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.